HRSA unveils revised 340B rebate pilot letting drugmakers deny rebates for some drugs.
HHS’ Health Resources and Services Administration unveiled details of a revised 340B rebate pilot, which will let some drug manufacturers deny rebates for a small …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The Trump administration is revising its rebate pilot for the 340B drug discount program, angering hospitals.
The Health Resources & Services Administration has unveiled its formal plans for a revised version of its contentious 340B Rebate…
An appellate court panel ruled Tuesday that drug manufacturers may not impose 340B rebates without approval from the U.S.…
After years of investigation, the outgoing chairman of the Senate Health, Education, Labor and Pensions Committee has released…
CMS proposes cutting Medicare 340B drug reimbursements to average sales price minus 33.4%, saving $4.55B in 2027. Hospital groups…
Under the 340B program, drug manufacturers provide medicines at steep discounts, which providers are supposed to pass on to…
